The director of the White House Office of Commerce and Manufacturing, Peter NavarroHe said that Congress should use the next stimulus package to get the pharmaceutical industry in China and India back to Puerto Rico.
The President’s Chief Business Advisor Donald trump expressed in an interview with the newspaper Washington Examiner than Puerto Rico could once again be a key player in the drug supply chain in the United States.
The issue emerges as one of national security seeking to make critical health supplies more affordable to the United States amid the COVID-19 pandemic.
“If you think about how the Puerto Rican economy is organized, there are more than 100 business parks around the island where these facilities could flourish,” said Navarro. “That is something that Capitol hill It could help facilitate with a little attention in the next phase. Puerto Rico had a thriving pharmaceutical industry, but Congress ended that, “he added.
It might interest you:
The representative of the American Virgin Islands before Congress, Stacey Plaskett, presented the House Bill 6648 entitled “Law for the economic recovery of the territories” (H.R. 6648, The Territorial Economic Recovery Act). This consists of providing incentives to both Puerto Rico and the rest of the North American territories for the pharmaceutical companies to return to the island.
The project announced by the candidate for the Puerto Rico resident police station by the Popular Democratic Party, Aníbal Acevedo Vilá, had the support of the Democratic congresswoman, Nydia Velásquez.
Meanwhile, the current resident commissioner, Jenniffer González, announced that she works with the Governor of Puerto Rico, Wanda Vázquez Garced, a project for the creation of “Distressed Zones”.
These areas would be those with a 35% sustained poverty level for a period of five years. The measure seeks to establish an application process so that certain areas can be designated as such to qualify for a series of benefits that would be in force for 15 years.
If medical equipment research and development pharmaceuticals and manufacturers are located in these areas, they would be eligible for a 40% tax credit for wages and benefits. Likewise, they would qualify for a depreciation of 40% of the manufacturing properties put into service, among others.
– .
